Bruton's tyrosine kinase (Btk) - The critical tyrosine kinase in LPS signalling?

Immunology Letters

Volumn 92, Issue 1-2, 2004, Pages 15-22

  Jefferies, Caroline A ^a   O'Neill, Luke A J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Btk; LPS; MAPK; NF B; TLR; Tyrosine kinase

Indexed keywords

BRUTON TYROSINE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN TYROSINE KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4;

AGAMMAGLOBULINEMIA; AUTOPHOSPHORYLATION; BINDING SITE; BONE MARROW CELL; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN;

ANIMALS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; NF-KAPPA B; PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 1842814062     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2003.11.017     Document Type: Conference Paper

References (52)

1. Akira S., Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85(2):2003;85-95.
2. O'Neill L.A., Fitzgerald K.A., Bowie A.G. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24(6):2003;286-290.
3. Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.L. et al. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273(20):1998;12203-12209.
4. Jefferies C., O'Neill L.A. Signal transduction pathway activated by Toll-like receptors. Mod. Asp. Immunobiol. 2:2002;169-175.
5. Dunne A., O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE. 2003(171):2003;re3.
6. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M.et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9(1):1998;143-150.
7. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11(1):1999;115-122.
8. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G.et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 413(6851):2001;78-83.
9. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2(9):2001;835-841.
10. Horng T., Barton G.M., Flavell R.A., Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature. 420(6913):2002;329-333.
11. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T.et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature. 420(6913):2002;324-329.
12. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K.et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169(12):2002;6668-6672.
13. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4(2):2003;161-167.
14. Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A., Latz E.et al. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198(7):2003;1043-1055.
15. Yamamoto M., Sato S., Hemmi H., Uematsu S., Hoshino K., Kaisho T.et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4(11):2003;1144-1150.
16. Singer A.L., Koretzky G.A. Control of T cell function by positive and negative regulators. Science. 296(5573):2002;1639-1640.
17. Latour S., Veillette A. Proximal protein tyrosine kinases in immunoreceptor signaling. Curr. Opin. Immunol. 13(3):2001;299-306.
18. Hsueh R.C., Scheuermann R.H. Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor. Adv. Immunol. 75:2000;283-316.
19. Ziegler S.F., Wilson C.B., Perlmutter R.M. Augmented expression of a myeloid-specific protein tyrosine kinase gene (hck) after macrophage activation. J. Exp. Med. 168(5):1988;1801-1810.
20. Boulet I., Ralph S., Stanley E., Lock P., Dunn A.R., Green S.P.et al. Lipopolysaccharide- and interferon-gamma-induced expression of hck and lyn tyrosine kinases in murine bone marrow-derived macrophages. Oncogene. 7(4):1992;703-710.
21. Geng Y., Zhang B., Lotz M. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J. Immunol. 151(12):1993;6692-6700.
22. Dearden-Badet M.T., Revillard J.P. Requirement for tyrosine phosphorylation in lipopolysaccharide-induced murine B-cell proliferation. Immunology. 80(4):1993;658-660.
23. Beaty C.D., Franklin T.L., Uehara Y., Wilson C.B. Lipopolysaccharide- induced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction. Eur. J. Immunol. 24(6):1994;1278-1284.
24. Orlicek S.L., Hanke J.H., English B.K. The src family-selective tyrosine kinase inhibitor PP1 blocks LPS and IFN-gamma-mediated TNF and iNOS production in murine macrophages. Shock. 12(5):1999;350-354.
25. Napolitani G., Bortoletto N., Racioppi L., Lanzavecchia A., D'Oro U. Activation of src-family tyrosine kinases by LPS regulates cytokine production in dendritic cells by controlling AP-1 formation. Eur. J. Immunol. 33(10):2003;2832-2841.
26. Meng F., Lowell C.A. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J. Exp. Med. 185(9):1997;1661-1670.
27. Vihinen M., Mattsson P.T., Smith C.I.E. BTK, the tyrosine kinase affected in X-linked agammaglobulinemia. Front Biosci. 2:1997;d27-42.
28. Bradley L.A., Sweatman A.K., Lovering R.C., Jones A.M., Morgan G., Levinsky R.J.et al. Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. Hum. Mol. Genet. 3(1):1994;79-83.
29. Hashimoto S., Tsukada S., Matsushita M., Miyawaki T., Niida Y., Yachie A.et al. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood. 88(2):1996;561-573.
30. Rawlings D.J., Saffran D.C., Tsukada S., Largaespada D.A., Grimaldi J.C., Cohen L.et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 261(5119):1993;358-361.
31. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2(10):2002;725-734.
32. Petro J.B., Rahman S.M., Ballard D.W., Khan W.N. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement. J. Exp. Med. 191(10):2000;1745-1754.
33. Bajpai U.D., Zhang K., Teutsch M., Sen R., Wortis H.H. Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation. J. Exp. Med. 191(10):2000;1735-1744.
34. Mukhopadhyay S., Sahoo P.K., George A., Bal V., Rath S., Ravindran B. Delayed clearance of filarial infection and enhanced Th1 immunity due to modulation of macrophage APC functions in xid mice. J. Immunol. 163(2):1999;875-883.
35. Mukhopadhyay S., Mohanty M., Mangla A., George A., Bal V., Rath S.et al. Macrophage effector functions controlled by Bruton's tyrosine kinase are more crucial than the cytokine balance of T cell responses for microfilarial clearance. J. Immunol. 168(6):2002;2914-2921.
36. Gagliardi M.C., Finocchi A., Orlandi P., Cursi L., Cancrini C., Moschese V.et al. Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function. Clin. Exp. Immunol. 133(1):2003;115-122.
37. Horwood N.J., Mahon T., McDaid J.P., Campbell J., Mano H., Brennan F.M. et al. Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production. J. Exp. Med. 197(12):2003;1603-1611.
38. Jefferies C.A., Doyle S., Brunner C., Dunne A., Brint E., Wietek C.et al. Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J. Biol. Chem. 278(28):2003;26258-26264.
39. Suzuki H., Terauchi Y., Fujiwara M., Aizawa S., Yazaki Y., Kadowaki T.et al. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science. 283(5400):1999;390-392.
40. Mao C., Zhou M., Uckun F.M. Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia. J. Biol. Chem. 276(44):2001;41435-41443.
41. Kurosaki T., Kurosaki M. Transphosphorylation of Bruton's tyrosine kinase on tyrosine 551 is critical for B cell antigen receptor function. J. Biol. Chem. 272(25):1997;15595-15598.
42. Jiang A., Craxton A., Kurosaki T., Clark E.A. Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase. J. Exp. Med. 188(7):1998;1297-1306.
43. Hashimoto S., Iwamatsu A., Ishiai M., Okawa K., Yamadori T., Matsushita M.et al. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK - functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. Blood. 94(7):1999;2357-2364.
44. Su Y.W., Zhang Y., Schweikert J., Koretzky G.A., Reth M., Wienands J. Interaction of SLP adaptors with the SH2 domain of Tec family kinases. Eur. J. Immunol. 29(11):1999;3702-3711.
45. Yang W., Desiderio S. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. Proc. Natl. Acad. Sci. U.S.A. 94(2):1997;604-609.
46. Novina C.D., Kumar S., Bajpai U., Cheriyath V., Zhang K., Pillai S.et al. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase. Mol. Cell Biol. 19(7):1999;5014-5024.
47. Webb C.F., Yamashita Y., Ayers N., Evetts S., Paulin Y., Conley M.E.et al. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. J. Immunol. 165(12):2000;6956-6965.
48. Marquez J.A., Smith C.I., Petoukhov M.V., Lo S.P., Mattsson P.T., Knekt M.et al. Conformation of full-length Bruton tyrosine kinase (Btk) from synchrotron X-ray solution scattering. EMBO J. 22(18):2003;4616-4624.
49. Cory G.O., Lovering R.C., Hinshelwood S., MacCarthy-Morrogh L., Levinsky R.J., Kinnon C. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J. Exp. Med. 182(2):1995;611-615.
50. Sohn H.W., Gu H., Pierce S.K. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk. J. Exp. Med. 197(11):2003;1511-1524.
51. Vos Q., Lees A., Wu Z.Q., Snapper C.M., Mond J.J. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 176:2000;154-170.
52. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 416(6881):2002;603-607.